An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response

BACKGROUND: The use of targeted therapy remains a treatment consideration for some patients with advanced Merkel cell carcinoma (MCC). However, supportive data on the use of targeted therapy approaches are limited. Thus, we sought to evaluate the responsiveness of targeted agents in patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Knepper, Todd C., Panchaud, Robyn A., Muradova, Elnara, Cohen, Leah, DeCaprio, James A., Khushalani, Nikhil I., Tsai, Kenneth Y., Brohl, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419775/
https://www.ncbi.nlm.nih.gov/pubmed/34269527
http://dx.doi.org/10.1002/cam4.4138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419775/
https://www.ncbi.nlm.nih.gov/pubmed/34269527
http://dx.doi.org/10.1002/cam4.4138

Ejemplares similares